Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00591097 · ClinicalTrials.gov registry record

Normal Reference Ranges for Urinary Metabolites and Supersaturation Indices in Pediatric Populations

A clinical trial of Healthy, sponsored by University of Wisconsin, Madison.

Completed
Registry status
300
Enrollment target
2
Study locations

NCT00591097: Completed study of Healthy, sponsored by University of Wisconsin, Madison.

NCT00591097 is a study of Healthy that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 300 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (54% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00591097, a study of Healthy, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
300 participants
Enrollment target
2
Study locations

Study Summary

The reported normal values used in diagnosing and treating pediatric kidney stone formers are based on adult values or historic data from small studies. Urinary supersaturation indices which are now described in the adult stone literature as more sensitive predictors of stone composition, and precise predictors of response to therapy, are not established in children. The goals of this prospective study are to redefine normal values for pediatric urinary metabolites and supersaturation indices based on samples from a large number of healthy children and to identify if a difference in urinary supersaturations in children is protective.

Conditions Studied

Study Locations (2)

Wisconsin

  • University of Wisconsin Hospital and Clinics - Madison
  • Charles Durkee, MD - Milwaukee

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2006-10
Est. Completion 2011-10
University of Wisconsin, Madison

1,039 total trials

What the finished NCT00591097 record still lists

NCT00591097 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (54% lower).

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 0 interventions.

NCT00591097 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT00591097 about?

NCT00591097 is a clinical study titled "Normal Reference Ranges for Urinary Metabolites and Supersaturation Indices in Pediatric Populations". The reported normal values used in diagnosing and treating pediatric kidney stone formers are based on adult values or historic data from small studies. Urinary supersaturation indices which are now described in the adult stone literature as more sensitive predictors of stone composition, and precis...

What is the current status of trial NCT00591097?

This trial is currently completed. The enrollment target is 300 participants. The study started on 2006-10. Estimated completion is 2011-10.

What conditions does trial NCT00591097 study?

This clinical trial studies the following conditions: Healthy.

Who is sponsoring clinical trial NCT00591097?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00591097 being conducted?

This trial has 2 study locations across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00591097's enrollment target sits among peer trials

300 77th of 1090 higher than 1,004 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00591097, the US trial registry maintained by the National Library of Medicine. NCT00591097 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.